Cargando…

Effect of Ibandronate Therapy on Serum Chemerin, Vaspin, Omentin-1 and Osteoprotegerin (OPG) in Postmenopausal Osteoporotic Females

Osteoporosis is a condition in which bone mineral density is reduced due to altered bone microstructure, which results in increased skeletal fragility and incidence of various types of fractures. Adipokines such as chemerin, vaspin, omentin-1 and osteoprotegerin are involved in bone remodeling. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tariq, Saba, Tariq, Sundus, Abualhamael, Shahad Abduljalil, Shahzad, Muhammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864312/ https://www.ncbi.nlm.nih.gov/pubmed/35222038 http://dx.doi.org/10.3389/fphar.2022.822671

Ejemplares similares

Osteoprotegerin genetic polymorphisms and their influence on therapeutic response to ibandronate in postmenopausal osteoporotic females
por: Tariq, Saba, et al.
Publicado: (2023)

Association of serum levels of Visfatin, Intelectin-1, RARRES2 and their genetic variants with bone mineral density in postmenopausal females
por: Tariq, Sundus, et al.
Publicado: (2022)

Association of serum chemerin with calcium, alkaline phosphatase and bone mineral density in postmenopausal females
por: Tariq, Saba, et al.
Publicado: (2021)

Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome
por: Guvenc, Yesim, et al.
Publicado: (2016)

Association of the Adipokines Chemerin, Apelin, Vaspin and Omentin and Their Functional Genetic Variants with Rheumatoid Arthritis
por: Wahba, Alaa S., et al.
Publicado: (2021)

Anti-inflammatory adipokines: chemerin, vaspin, omentin concentrations and SARS-CoV-2 outcomes
por: Kukla, Michał, et al.
Publicado: (2021)

Association of serum osteoprotegerin with severity of chronic liver disease in female patients: A potential biomarker
por: Tariq, Saba, et al.
Publicado: (2020)

Circulating levels of the adipocytokines vaspin and omentin in patients with Kawasaki disease
por: Cantarini, L, et al.
Publicado: (2011)

The role of the novel adipokines vaspin and omentin in chronic inflammatory diseases
por: Radzik-Zając, Joanna, et al.
Publicado: (2022)

Alkaline phosphatase is a predictor of Bone Mineral Density in postmenopausal females
por: Tariq, Sundus, et al.
Publicado: (2019)

Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
por: Wasilewska, Anna, et al.
Publicado: (2010)

Comparison of parameters of bone profile and homocysteine in physically active and non-active postmenopausal females
por: Tariq, Sundus, et al.
Publicado: (2016)

Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis
por: Kukla, Michał, et al.
Publicado: (2017)

The Effect of the Ketogenic Diet on Adiponectin, Omentin and Vaspin in Children with Drug-Resistant Epilepsy
por: Chyra, Marcin, et al.
Publicado: (2022)

Expression of Serum Omentin, CTRP9, and Vaspin in Patients with Polycystic Ovary Syndrome
por: Wang, Yuhong, et al.
Publicado: (2022)

The potential influence of hyperthyroidism on circulating adipokines chemerin, visfatin, and omentin
por: Alshaikh, Eman M., et al.
Publicado: (2019)

Association Between Vitamin D and Resistin in Postmenopausal Females With Altered Bone Health
por: Tariq, Sundus, et al.
Publicado: (2021)

CanSino COVID-19 Vaccine: Comparison of Vaccine Adverse Effects Among Diabetic and Non-diabetic Recipients
por: Abualhamael, Shahad Abduljalil, et al.
Publicado: (2023)

Are Vaspin and Omentin-1 Related to Insulin Resistance, Blood Pressure and Inflammation in NAFLD Patients?
por: Aliasghari, Fereshteh, et al.
Publicado: (2018)

Osteoprotegerin (OPG) as a biomarker for diabetic cardiovascular complications
por: Bjerre, Mette
Publicado: (2013)

Role of Omentin, Vaspin, Cardiotrophin-1, TWEAK and NOV/CCN3 in Obesity and Diabetes Development
por: Escoté, Xavier, et al.
Publicado: (2017)

Comparison of Monthly Ibandronate Versus Weekly Risedronate in Preference, Convenience, and Bone Turnover Markers in Korean Postmenopausal Osteoporotic Women
por: Chung, Yoon-Sok, et al.
Publicado: (2009)

Osteoprotegerin (OPG) gene therapy in animal models of osteoarticular disease
por: Bolon, B, et al.
Publicado: (2001)

Flutamide Alters the Expression of Chemerin, Apelin, and Vaspin and Their Respective Receptors in the Testes of Adult Rats
por: Brzoskwinia, Malgorzata, et al.
Publicado: (2020)

Status of bone health and association of socio-demographic characteristics with Bone Mineral Density in Pakistani Females
por: Tariq, Saba, et al.
Publicado: (2019)

Serum omentin-1, vaspin, and apelin levels and central obesity in patients with nonalcoholic fatty liver disease
por: Montazerifar, Farzaneh, et al.
Publicado: (2017)

Correlation of Serum Vaspin, Omentin-1, and adiponectin with metabolic phenotypes in Type-2 diabetes mellitus patients
por: Baig, Mukhtiar, et al.
Publicado: (2021)

The genetic association between osteoprotegerin (OPG) gene polymorphisms and bone mineral density (BMD) in postmenopausal women: A meta-analysis
por: Peng, Yuqin, et al.
Publicado: (2018)

Serum Resistin Levels and Related Genetic Variants Are Associated With Bone Mineral Density in Postmenopausal Women
por: Tariq, Sundus, et al.
Publicado: (2022)

Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women
por: Sambrook, Philip
Publicado: (2007)

New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women
por: Auguet, Teresa, et al.
Publicado: (2011)

The genetic association between osteoprotegerin (OPG) gene polymorphisms and bone mineral density (BMD) in postmenopausal women: A meta-analysis: Erratum
Publicado: (2019)

Association of Serum Omentin-1, Chemerin, and Leptin with Acute Myocardial Infarction and its Risk Factors
por: Baig, Mukhtiar, et al.
Publicado: (2020)

High-Intensity Interval Training Does Not Change Vaspin and Omentin and Does Not Reduce Visceral Adipose Tissue in Obese Rats
por: Costa, Leandro Ribeiro, et al.
Publicado: (2021)

Ibandronate: the first once-monthly oral bisphosphonate for treatment of postmenopausal osteoporosis
por: Bauss, Frieder, et al.
Publicado: (2006)

Association between omentin-1, adiponectin and bone health under consideration of osteoprotegerin as possible mediator
por: Menzel, J., et al.
Publicado: (2016)

Association between chemerin, omentin-1 and risk of heart failure in the population-based EPIC-Potsdam study
por: Menzel, Juliane, et al.
Publicado: (2017)

Alendronate (ALN) combined with Osteoprotegerin (OPG) significantly improves mechanical properties of long bone than the single use of ALN or OPG in the ovariectomized rats
por: Wang, Yan, et al.
Publicado: (2011)

Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms
por: Eid, Riham, et al.
Publicado: (2023)

Long-term efficacy, safety, and patient acceptability of ibandronate in the treatment of postmenopausal osteoporosis
por: Inderjeeth, Charles A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2sb2tk6u2eug7a42l4akkmkjmv